Lupin’s arm inks commercial agreement with Creso for hemp oil based cannaQIX

26 Aug 2019 Evaluate

Lupin’s subsidiary in South Africa-- ‘Pharma Dynamics’ has signed a Commercial Agreement with Creso Pharma (Creso) for the hemp oil based cannaQIX. Creso affords Pharma Dynamics sole distribution rights of its organic, broad spectrum hemp oil nutraceutical, cannaQIX10, across South Africa, Namibia, Botswana, Zimbabwe, Swaziland, Lesotho, Angola, Mozambique and Uganda. 

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2114.00 24.35 (1.17%)
17-Dec-2025 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1775.25
Dr. Reddys Lab 1271.15
Cipla 1493.80
Zydus Lifesciences 917.60
Lupin 2114.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×